Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Revitalist Lifestyle and Wellness Ltd. C.CALM

Alternate Symbol(s):  RVLWF

Revitalist Lifestyle and Wellness Ltd. is a mental health company. The Company is primarily engaged in the provision of psychotherapy services. It provides ketamine-assisted psychotherapy and other treatments through its network of integrative mental health clinics. The Company’s segments include Clinical Operations and Research. Its Clinical Operations segment encompass the Company’s ketamine... see more

Recent & Breaking News (CSE:CALM)

Revitalist Achieves 300% Month Over Month Growth Serving Veterans with Psychedelic Therapies in the US with Coverage from VA

Business Wire September 8, 2022

Revitalist Updates Infrastructure for Aggressive Growth Strategy in 2022

Business Wire August 29, 2022

Awakn (NEO:AWKN) expands into the U.S. with first licensing partnership agreement with Revitalist (CSE:CALM)

Azuka Onwuka August 15, 2022

Awakn Life Sciences Expands Commercial Operations into the U.S. - First Licensing Partnership Agreement with Revitalist

Newsfile August 15, 2022

 Revitalist Partners with Awakn Life Sciences as First Licensee in the United States to begin Redefining Treatment for Addiction, Recovery, and Relapse Prevention in the Psychedelic Space

Business Wire August 15, 2022

Revitalist Announces Release of Three Proprietary Service Lines Advancing Their Comprehensive Footprint in the Mental Health and Psychedelic Wellness Space

Business Wire August 8, 2022

Revitalist Exceeds Growth Expectations in the Month of June with Record Breaking Visits While Also Advancing Their Reach for Veterans Across the United States

Business Wire July 13, 2022

Revitalist Announces Close of Private Placement Totaling $3,944,000

Business Wire June 15, 2022

Revitalist Reports Q1 2022 Financial Results and Provides Business Update

Business Wire May 30, 2022

Revitalist's Strategic Initiatives Continue to Exceed Expectations for Execution Giving Company Record High Revenues Since Opening in 2018.

Business Wire May 12, 2022

Revitalist Reports 2021 Financial Results and Provides Business Update

Business Wire May 2, 2022

Revitalist Reports Fourteen Months of Consecutive Monthly Visit Growth and a 466% Increase Year over Year for March 2022

Business Wire April 20, 2022

Revitalist CEO Invests $2,332,000 in the Company's First Tranche Financing of $3,869,000

Business Wire April 19, 2022

Revitalist Announces Private Placement Offering of up To CDN$6 Million

Business Wire April 6, 2022

Revitalist Addresses Opioid Epidemic Through Non-Medicative Interventions with TMS Representing a $195 Billion USD Market

Business Wire April 5, 2022

Revitalist Increases Clinic Count to 10 with the Acquisition of a Virginia Ketamine Clinic

Business Wire March 29, 2022

Revitalist Launches UNIT Initiative Working With Veteran and First Responder Non-Profits Across the United States Creating Nationwide Guidelines

Business Wire March 22, 2022

Revitalist Reports Thirteen Months of Consecutive Monthly Visit Growth and a 427% Increase Year Over Year for February 2022

Business Wire March 15, 2022

Revitalist and PharmaTher Announce Collaboration to Develop and Advance Novel and Standardized Ketamine Treatment Protocols for Mental Health Disorders and Chronic Pain Syndromes

Business Wire March 1, 2022

Revitalist Receives Approval from Biomedical Research Alliance of New York Permitting the Company to Perform Human Subjects Clinical Trials

Business Wire February 24, 2022